Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285740 · ClinicalTrials.gov registry record · NA
Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00285740: Completed NA study, sponsored by Stanford University.
NCT00285740 is a NA study that has completed, run by Stanford University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00285740, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy. The CBT groups will be tailored for an epilepsy clinic population. There are 12 sessions of therapy in the study held once a week for 12 weeks.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT) in a Group Format
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-01 |
| Phase | NA |
What the finished NCT00285740 record still lists
NCT00285740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT) in a Group Format is the first listed.
NCT00285740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00285740 about?
NCT00285740 is a clinical study titled "Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting". This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy. The CBT groups will be tailored for an epilepsy clinic population. There are 12 sessions of therapy in the study held once a week for 12 weeks.
What is the current status of trial NCT00285740?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2005-08. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00285740?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) in a Group Format (BEHAVIORAL).
Who is sponsoring clinical trial NCT00285740?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00285740's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia